Titan Biotech Closes Trading Window for Bonus Share Board Meeting

Titan Biotech Ltd has announced the closure of its trading window for all designated persons, their immediate relatives, and connected persons. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's code of conduct. The trading window will remain shut until 48 hours after the conclusion of the Board Meeting scheduled for Thursday, September 03, 2026. The primary purpose of this meeting is to consider a proposal for the issue of Bonus Shares, subject to necessary approvals. All relevant parties have been duly informed not to engage in any trading of the company's securities during this period.